Company Overview of Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc. develops therapeutics to treat ischemia-reperfusion injury. Faraday Pharmaceuticals, Inc. was formerly known as Scion Pharmaceuticals, Inc. The company was incorporated in 2013 and is based in Seattle, Washington.
1616 Eastlake Avenue East
Seattle, WA 98102
Founded in 2013
Key Executives for Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Faraday Pharmaceuticals, Inc., please visit faradaypharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.